Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription initiation factor TFIID subunit 9B (TAF9B) is a subunit of the multiprotein TFIID complex, which is essential for the initiation of RNA polymerase II-mediated transcription[1][2][3][4][6]. TAF9B shares some functions with its paralog TAF9, but also has unique roles in regulating distinct gene sets[2][6]. TAF9B is necessary for cell viability and is involved in both transcriptional activation and repression. It may play a role in the regulation of apoptosis and participates in complex assembly and control of gene expression in eukaryotic cells[2][4]. Notably, TAF9B itself is not a conventional therapeutic target such as a receptor, enzyme, or transporter; it acts primarily as a core transcription regulatory factor. The gene listed in your query, ENSG00000253176, refers to a pseudogene (LOC100130612)[4], and not the active coding gene (ENSG00000187325). Thus, ENSG00000253176 likely does not code for a functional protein, and should not be considered a protein-coding drug target.
Not applicable (no drug interactions reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription initiation factor TFIID subunit 9B (TAF9B).